- Published on May 15, 2025
- In GCC
Trump Tariff to Push Indian Pharma Co to Embrace AI, Cost-Efficient R&D
The proposed 10% tariff, which mirrors India’s tax on US drug imports, could severely impact profit margins for generic drug producers.
- By Shalini Mondal
U.S. President Donald Trump announced a 59% reduction in prescription drug prices earlier this week, just a day after unveiling a new US pharmaceutical policy. He emphasised the government would eliminate intermediaries and enable the direct sale of medications to American citizens at the most favoured nation (MFN) price.
The announcement sent ripples through the healthcare sector, especially given ongoing concerns surrounding pharmaceutical pricing and supply chain stability. It also risks triggering drug shortages or price hikes within America’s healthcare system.
Purav Gandhi, founder and CEO of Healthark, spoke with AIM and said this development is an opportunity for India.
“The move by the U.S. Government would push pharma companies to move R&D centres to low-co
📣 Want to advertise in AIM? Book here
Shalini Mondal
Shalini is a senior tech journalist, exploring the latest advancements in AI. When she's not reporting on the latest innovations, you can find her immersed in her next literary adventure.
Related Posts
Enterprises Beware: Agent-Washing Clouds the Future of AI
Vendors mislabel copilots as agents, raising regulatory and operational risks for firms chasing the promise of agentic AI.
How Neysa Stands Out in the IndiaAI GPU Race
Unlike other providers focused on GPU allocation, Neysa claims to deliver an end-to-end AI cloud platform.
BharatGen and the Pursuit of Sovereign, Scalable AI for India
“Knowledge-driven components are important because we don’t want everything to be just algorithmic innovation.”
How Pradhi AI Embeds Emotional Intelligence in Voice AI
As businesses recognise the potential of voice-driven tech, Pradhi AI is laying the foundation for an empathetic, responsive AI ecosystem.
Mangaluru Looks to Build Its Own Tech Identity, Not Replicate Bangalore
“The coastal city could showcase tangible results by applying deep tech to areas it already dominates”
Google’s Gemini Nano Banana and the Cost of Convenience
The company’s new AI image and photo editor deepens concerns over data use and consent gaps, experts warn.
BharatGen’s ‘Recipe’ for Building a Trillion Parameters Indic Model
The consortium insists sovereignty doesn’t mean shutting the door on global players.
Storytelling is in the Creator’s Control with GenAI
“Democracy would not have been possible without storytelling being distributed.”
Download the easiest way to
stay informed
stay informed
